Logo image of NBVA.CA

NUBEVA TECHNOLOGIES LTD (NBVA.CA) Stock Fundamental Analysis

TSX-V:NBVA - TSX Venture Exchange - CA67021Y1097 - Common Stock - Currency: CAD

0.135  -0.01 (-6.9%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NBVA. NBVA was compared to 66 industry peers in the Software industry. The financial health of NBVA is average, but there are quite some concerns on its profitability. NBVA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NBVA has reported negative net income.
In the past year NBVA has reported a negative cash flow from operations.
In the past 5 years NBVA always reported negative net income.
In the past 5 years NBVA always reported negative operating cash flow.
NBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFNBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

NBVA's Return On Assets of -0.92% is fine compared to the rest of the industry. NBVA outperforms 62.12% of its industry peers.
Looking at the Return On Equity, with a value of -0.96%, NBVA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
ROA -0.92%
ROE -0.96%
ROIC N/A
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
NBVA.CA Yearly ROA, ROE, ROICNBVA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

NBVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBVA.CA Yearly Profit, Operating, Gross MarginsNBVA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

6

2. Health

2.1 Basic Checks

NBVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NBVA has more shares outstanding than it did 1 year ago.
NBVA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NBVA is higher compared to a year ago.
NBVA.CA Yearly Shares OutstandingNBVA.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NBVA.CA Yearly Total Debt VS Total AssetsNBVA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

NBVA has an Altman-Z score of 19.15. This indicates that NBVA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NBVA (19.15) is better than 92.42% of its industry peers.
NBVA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, NBVA belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.15
ROIC/WACCN/A
WACC13.97%
NBVA.CA Yearly LT Debt VS Equity VS FCFNBVA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 24.46 indicates that NBVA has no problem at all paying its short term obligations.
NBVA has a Current ratio of 24.46. This is amongst the best in the industry. NBVA outperforms 95.45% of its industry peers.
NBVA has a Quick Ratio of 24.46. This indicates that NBVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 24.46, NBVA belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 24.46
Quick Ratio 24.46
NBVA.CA Yearly Current Assets VS Current LiabilitesNBVA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.93% over the past year.
NBVA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -78.47%.
NBVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.15% yearly.
EPS 1Y (TTM)89.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.93%
Revenue 1Y (TTM)-78.47%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-82.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBVA.CA Yearly Revenue VS EstimatesNBVA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
NBVA.CA Yearly EPS VS EstimatesNBVA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -0.01 -0.02 -0.03 -0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NBVA.CA Price Earnings VS Forward Price EarningsNBVA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NBVA.CA Per share dataNBVA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NBVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUBEVA TECHNOLOGIES LTD

TSX-V:NBVA (2/21/2025, 7:00:00 PM)

0.135

-0.01 (-6.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-18 2024-12-18
Earnings (Next)03-21 2025-03-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.71%
Ins Owner ChangeN/A
Market Cap9.47M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.17
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.92%
ROE -0.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.46
Quick Ratio 24.46
Altman-Z 19.15
F-Score4
WACC13.97%
ROIC/WACCN/A
Cap/Depr(3y)305.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-78.47%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-82.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.46%
OCF growth 3YN/A
OCF growth 5YN/A